X.J. Meng

Dr. Xiang-Jin "X.J." Meng studies emerging and re-emerging viral diseases that impact veterinary and human public health. He is widely considered one of the world’s leading scientists on hepatitis E virus, porcine circovirus type 2, and porcine reproductive and respiration syndrome virus. His laboratory developed the first USDA fully licensed vaccine to protect against porcine circovirus type 2 infection and its associated diseases in pigs, a major threat to the global swine industry. Dr. Meng also discovered swine hepatitis E virus in pigs, which led to a paradigm shift and the recognition of hepatitis E as a zoonotic disease that can infect across the species barrier.

Dr. Meng has authored or co-authored more than 300 peer-reviewed articles and book chapters. He has been awarded research grants as a PI totaling more than $17 million, and he is also a co-investigator on other awarded grants of more than $28 million. Dr. Meng is a named inventor on 21 awarded and 17 pending U.S. patents, as well as 40 awarded foreign patents.